These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neurochemical dementia diagnostics for Alzheimer's disease and other dementias: an ISO 15189 perspective. Waedt J; Kleinow M; Kornhuber J; Lewczuk P Biomark Med; 2012 Oct; 6(5):685-90. PubMed ID: 23075248 [TBL] [Abstract][Full Text] [Related]
3. The role of CSF biomarkers in the diagnostic work-up of mixed vascular-degenerative dementia. Engelborghs S; Le Bastard N J Neurol Sci; 2012 Nov; 322(1-2):197-9. PubMed ID: 22947896 [TBL] [Abstract][Full Text] [Related]
4. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Vanderstichele H; Bibl M; Engelborghs S; Le Bastard N; Lewczuk P; Molinuevo JL; Parnetti L; Perret-Liaudet A; Shaw LM; Teunissen C; Wouters D; Blennow K Alzheimers Dement; 2012 Jan; 8(1):65-73. PubMed ID: 22047631 [TBL] [Abstract][Full Text] [Related]
5. Neurochemical dementia diagnostics: State of the art and research perspectives. Lewczuk P; Wiltfang J Proteomics; 2008 Mar; 8(6):1292-301. PubMed ID: 18271068 [TBL] [Abstract][Full Text] [Related]
6. Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementia. Le Bastard N; Coart E; Vanderstichele H; Vanmechelen E; Martin JJ; Engelborghs S J Alzheimers Dis; 2013; 33(1):117-31. PubMed ID: 22936010 [TBL] [Abstract][Full Text] [Related]
8. Added diagnostic value of CSF biomarkers in differential dementia diagnosis. Le Bastard N; Martin JJ; Vanmechelen E; Vanderstichele H; De Deyn PP; Engelborghs S Neurobiol Aging; 2010 Nov; 31(11):1867-76. PubMed ID: 19150153 [TBL] [Abstract][Full Text] [Related]
9. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand. Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431 [TBL] [Abstract][Full Text] [Related]
10. Neurochemical dementia diagnostics in Alzheimer's disease: where are we now and where are we going? Lewczuk P; Kornhuber J Expert Rev Proteomics; 2011 Aug; 8(4):447-58. PubMed ID: 21819301 [TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid Aβ1-40 improves differential dementia diagnosis in patients with intermediate P-tau181P levels. Slaets S; Le Bastard N; Martin JJ; Sleegers K; Van Broeckhoven C; De Deyn PP; Engelborghs S J Alzheimers Dis; 2013; 36(4):759-67. PubMed ID: 23666174 [TBL] [Abstract][Full Text] [Related]